L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Hypertension in Moderate-to-Severe Nondiabetic CKD Patients
Julian Segura,Luis M. Ruilope +1 more
TL;DR: Elevated blood pressure and the amount of albumin present in urine are the 2 most relevant factors facilitating the progression of chronic kidney disease in hypertensive patients.
Journal ArticleDOI
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.
Faiez Zannad,Patrick Rossignol,Wendy Gattis Stough,Murray Epstein,Maria Angeles Alonso Garcia,George L. Bakris,Javed Butler,Mikhail Kosiborod,Lance Berman,Alexandre Mebazaa,Henrik S. Rasmussen,Luis M. Ruilope,Norman Stockbridge,Aliza Thompson,Janet Wittes,Bertram Pitt +15 more
TL;DR: In this article, the authors summarized and expanded upon a discussion at the Global Cardiovascular Clinical Trialists 2014 Forum and examined methodologic considerations for trials of new potassium binders for the prevention and management of hyperkalemia in patients with renin angiotensin aldosterone system inhibitor indications.
Journal ArticleDOI
Target organ damage: how to detect it and how to treat it?
TL;DR: The early detection of cardiac organ damage in clinical practice is primordial for cardiovascular risk profiling of patients with hypertension, and the determination of microalbuminuria is very appealing because it increasingly appears to be the most cost-effective means to identify cardiovascular and renal complications.
Journal Article
Renal aspects of the hypertension optimal treatment (HOT) study
Journal ArticleDOI
Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
Luis M. Ruilope,Bridget-Anne Kirwan,Sophie de Brouwer,Nicolas Danchin,Keith A.A. Fox,Gilbert Wagener,Julian Segura,Philip A. Poole-Wilson,Jacobus Lubsen +8 more
TL;DR: It is concluded that, in patients with stable angina, nifedipine reduces uric acid levels and does not affect other markers of renal dysfunction, and Renal dysfunction does not alter the effects of nifingipine on clinical outcome.